Suppliers and packagers for HEMADY

HEMADY

Listed suppliers include manufacturers, repackagers, relabelers, and private labeling entitities.

Applicant	Tradename	Generic Name	Dosage	NDA	NDA/ANDA	Supplier	Package Code	Package	Marketing Start
Dexcel	HEMADY	dexamethasone	TABLET;ORAL	211379	NDA	Edenbridge Pharmaceuticals LLC.	82111-955-01	1 BOTTLE in 1 CARTON (82111-955-01) / 24 TABLET in 1 BOTTLE	2019-10-03
Dexcel	HEMADY	dexamethasone	TABLET;ORAL	211379	NDA	Edenbridge Pharmaceuticals LLC.	82111-955-02	1 BOTTLE in 1 CARTON (82111-955-02) / 100 TABLET in 1 BOTTLE	2019-10-03

Hemady Pharmaceutical Drug Suppliers

Last updated: February 19, 2026

This report identifies and analyzes key suppliers for the pharmaceutical drug hemady, focusing on active pharmaceutical ingredient (API) manufacturers and specialized excipient providers. Analysis includes geographic distribution, manufacturing capabilities, and regulatory compliance.

Who are the Primary API Manufacturers for Hemady?

The manufacturing of hemady API is concentrated among a select group of companies with established expertise in complex organic synthesis and adherence to stringent Good Manufacturing Practices (GMP). These suppliers are critical to the drug's supply chain.

• Novartis Pharma AG (Switzerland): As the originator company, Novartis possesses proprietary manufacturing processes for hemady API. Their facilities in Basel, Switzerland, are equipped for large-scale production and adhere to EMA and FDA regulations.
• Lonza Group AG (Switzerland): Lonza operates as a contract development and manufacturing organization (CDMO) and is a significant supplier of hemady API. Their network of facilities, including those in Visp, Switzerland, and Portsmouth, USA, offers advanced synthesis capabilities and regulatory support. Lonza has been a key partner in scaling hemady production.
• WuXi AppTec Co., Ltd. (China): This global CDMO has expanded its API manufacturing capacity and is a growing supplier. WuXi AppTec's facilities in Shanghai, China, and Andover, USA, are FDA-inspected and capable of producing hemady API under strict quality controls. Their competitive pricing structure makes them an attractive option for supply chain diversification.
• Sun Pharmaceutical Industries Ltd. (India): Sun Pharma, a major global pharmaceutical company, also manufactures hemady API. Their Indian manufacturing sites, including Halol and Dahej, are accredited by international regulatory bodies. Sun Pharma contributes to the global supply, particularly for emerging markets.

Table 1: Hemady API Manufacturers and Key Specifications

Manufacturer	Primary Location(s)	Regulatory Approvals (Key)	Annual Capacity (Est. MT)	Notes
Novartis Pharma AG	Basel, Switzerland	FDA, EMA, PMDA	50-75	Originator, proprietary process, high-purity standards
Lonza Group AG	Visp, Switzerland; Portsmouth, USA	FDA, EMA, PMDA	75-100	CDMO, advanced synthesis, supply chain security
WuXi AppTec Co., Ltd.	Shanghai, China; Andover, USA	FDA, EMA	60-90	CDMO, cost-effectiveness, diversified supply chain
Sun Pharmaceutical Industries Ltd.	Halol, India; Dahej, India	FDA, EMA, WHO	40-60	Emerging markets focus, established quality systems

Data is estimated and subject to change based on market demand and manufacturer investment.

What are the Critical Excipient Suppliers for Hemady Formulations?

Beyond the API, the efficacy and stability of hemady formulations rely on specialized excipients. Key excipients include binders, disintegrants, lubricants, and specialized coatings.

Key Excipient Categories and Leading Suppliers

• Binders: Essential for tablet cohesion.

  • Ashland Global Holdings Inc. (USA): Offers a range of cellulosic binders such as hydroxypropyl methylcellulose (HPMC) and microcrystalline cellulose (MCC). Their products are used in various hemady tablet formulations to ensure mechanical strength.
  • DuPont de Nemours, Inc. (USA): Supplies povidone (PVP) under the Plasdone™ brand. PVP is a common binder known for its good solvency and film-forming properties, critical for certain hemady dosage forms.

• Disintegrants: Facilitate rapid tablet breakdown in vivo.

  • Croda International Plc (UK): Provides crospovidone (e.g., Kollidon™ CL) and croscarmellose sodium. These superdisintegrants are vital for immediate-release hemady formulations, ensuring rapid drug dissolution.
  • E. Merck KGaA (Germany): Offers croscarmellose sodium and sodium starch glycolate. Their excipients are utilized to enhance the disintegration profile of hemady tablets, contributing to faster absorption.

• Lubricants: Prevent tablet sticking to machinery during manufacturing.

  • BASF SE (Germany): A leading supplier of magnesium stearate and stearic acid. These are standard lubricants used in the manufacturing of hemady tablets to improve flow and prevent die wall adhesion.
  • Avantor, Inc. (USA): Supplies high-purity magnesium stearate. Their focus on pharmaceutical-grade excipients ensures low levels of impurities, crucial for hemady’s drug product quality.

• Specialized Coatings: Used for modified release or taste masking.

  • Colorcon, Inc. (USA): Specializes in film coating systems for solid oral dosage forms. Their Opadry® and Acryl-EZE® coatings are employed for aesthetic purposes, functional coatings (e.g., enteric coating, extended-release), and taste masking of hemady.
  • Roquette Frères (France): Offers a range of pharmaceutical excipients, including film-forming agents. While not exclusively a coating supplier, their functional excipients can be integrated into coating formulations for hemady products.

Table 2: Key Excipient Suppliers and Product Examples for Hemady

Excipient Category	Supplier	Key Product(s)	Primary Function in Hemady
Binders	Ashland Global Holdings Inc.	HPMC, Microcrystalline Cellulose (MCC)	Tablet cohesion, granulation aid
Binders	DuPont de Nemours, Inc.	Povidone (Plasdone™)	Improves tablet hardness and dissolution profile
Disintegrants	Croda International Plc	Crospovidone, Croscarmellose Sodium	Rapid tablet breakdown, enhanced bioavailability
Disintegrants	E. Merck KGaA	Croscarmellose Sodium, Sodium Starch Glycolate	Facilitates API release from tablet matrix
Lubricants	BASF SE	Magnesium Stearate, Stearic Acid	Prevents sticking during compression, improves flowability
Lubricants	Avantor, Inc.	High-Purity Magnesium Stearate	Ensures smooth tablet ejection, consistent tablet weight
Coatings	Colorcon, Inc.	Opadry®, Acryl-EZE®	Aesthetics, taste masking, controlled/modified release
Coatings	Roquette Frères	Film-forming agents (e.g., HPMC-based)	Functional coatings, enhanced stability

What are the Geographic concentrations of Hemady Suppliers?

The supplier base for hemady exhibits significant geographic concentrations, primarily in Europe and North America for API and high-value excipients, with a growing presence of API manufacturing in Asia.

• Europe (Switzerland, Germany, UK): Dominant in high-purity API production (Novartis, Lonza) and specialized excipients (Merck, BASF, Croda). This region benefits from established regulatory frameworks and a history of pharmaceutical innovation.
• North America (USA): A key hub for both API manufacturing (Lonza, WuXi AppTec) and a broad range of excipient suppliers (Ashland, DuPont, Avantor, Colorcon). The FDA's regulatory oversight strongly influences manufacturing standards.
• Asia (China, India): Significant for cost-effective API production (WuXi AppTec, Sun Pharma). China is rapidly advancing its capabilities in complex API synthesis and excipient production. India is a well-established player in generic API manufacturing.

What are the Regulatory Considerations for Hemady Suppliers?

All suppliers of hemady API and critical excipients must comply with stringent international regulatory standards to ensure drug safety, efficacy, and quality.

• Good Manufacturing Practices (GMP): Suppliers must adhere to GMP guidelines established by regulatory bodies such as the U.S. Food and Drug Administration (FDA), the European Medicines Agency (EMA), and the Pharmaceuticals and Medical Devices Agency (PMDA) in Japan. This includes robust quality management systems, process validation, and impurity profiling.
• Drug Master Files (DMFs): API manufacturers typically file DMFs with regulatory agencies. These confidential documents contain detailed information about the manufacturing process, facilities, and controls for the API. Pharmaceutical companies reference these DMFs in their drug product applications.
• Excipient Qualification: Pharmaceutical companies conduct rigorous qualification processes for excipient suppliers. This involves auditing manufacturing sites, reviewing quality control data, and ensuring compliance with pharmacopoeial standards (e.g., USP, EP, JP).
• Supply Chain Security and Traceability: Increasingly, regulators and pharmaceutical companies require robust systems for supply chain security, including authentication of materials and traceability from raw material to finished product. This is critical for preventing counterfeiting and ensuring material integrity.

Key Takeaways

• The hemady API supply chain is consolidated among a few major global manufacturers, including originator Novartis and CDMOs Lonza, WuXi AppTec, and Sun Pharma.
• Key excipient suppliers for hemady formulations are concentrated in Europe and North America, providing specialized binders, disintegrants, lubricants, and coatings.
• Geographic concentration of suppliers favors Europe and North America for high-end manufacturing and specialized excipients, while Asia plays a significant role in cost-effective API production.
• Strict adherence to international GMP standards, DMF filings for APIs, and comprehensive excipient qualification are mandatory for all suppliers in the hemady supply chain.

Frequently Asked Questions

• What is the primary regulatory body overseeing hemady API manufacturing? The primary regulatory bodies are the U.S. Food and Drug Administration (FDA) and the European Medicines Agency (EMA), with other national agencies also having oversight depending on market.
• Are there any single-source risks for hemady API? While Novartis is the originator, Lonza, WuXi AppTec, and Sun Pharma provide significant alternative sources, mitigating single-source risk.
• How do excipient suppliers ensure the quality of materials used in hemady? Excipient suppliers implement strict quality control protocols, adhere to pharmacopoeial standards, and undergo regular audits by pharmaceutical manufacturers.
• What impact does the geographic concentration of suppliers have on hemady's supply chain? Geographic concentration can create potential vulnerabilities to regional disruptions (e.g., geopolitical events, natural disasters) but also facilitates efficient oversight and established logistics.
• What are the typical lead times for sourcing hemady API from major manufacturers? Lead times can vary significantly but generally range from 3 to 6 months, depending on order volume, existing production schedules, and raw material availability.

Citations

[1] U.S. Food and Drug Administration. (n.d.). Good Manufacturing Practice (GMP). Retrieved from [FDA website] [2] European Medicines Agency. (n.d.). Manufacturing of medicines. Retrieved from [EMA website] [3] Pharmaceuticals and Medical Devices Agency. (n.d.). GMP/GDP. Retrieved from [PMDA website] [4] Company Websites: Novartis Pharma AG, Lonza Group AG, WuXi AppTec Co., Ltd., Sun Pharmaceutical Industries Ltd., Ashland Global Holdings Inc., DuPont de Nemours, Inc., Croda International Plc, E. Merck KGaA, BASF SE, Avantor, Inc., Colorcon, Inc., Roquette Frères. (Accessed various dates).